About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Solara Active Pharma Sciences Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
541540
ISIN Demat
INE624Z01016
Book Value
261.71
NSE Code
SOLARA
Dividend Yield %
0.00
Market Cap
28507.04
P/E
776.76
EPS
0.76
Face Value
10
BSE
NSE
15-Dec-2025
BSE
NSE
NSE F & O
15-Dec-2025
BSE
NSE
NSE F & O
Last Price
591.80
Net Change
1.8
% Change
0.31%
Prev.Close
590.00
Open
590.00
High
595.00
Low
584.05
Volume
2700
Last Price
592.90
Net Change
2.4
% Change
0.41%
Prev.Close
590.50
Open
582.90
High
599.80
Low
582.45
Volume
72655
Value
1592670
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
595.00
52-Week High
765.55
52-Week Low
441.10
Value
42945829.5
Best Buy
0.00
Best Sell
592.90
Best Quantity
0
Sell Quantity
43
Today's Range
599.80
52-Week High
766.45
52-Week Low
442.80
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
43
Price
592.90
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
18-Sep-24
20-Sep-24
Rights
1 : 3
15-May-24
Dividend
30 %
21-Aug-21
Company News
04-12-2025
Clarification On Volume ...
19-11-2025
USFDA completes inspectio...
19-11-2025
Solara Active Pharma Sci...
26-09-2025
Clarification sought fro...
16-08-2025
Solara Active Pharma Scie...
25-07-2025
Solara Active Pharma Sci...
10-05-2025
USFDA concludes inspectio...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
